News

March 17, 2016March 18, 2016

New Mesothelioma Drug, HXR9, Seen to Induce Cell Death in Tumors for a First Time

News

Researchers confirmed in a new study that HOX genes are potential therapeutic targets for the treatment of mesothelioma, and demonstrated that a new drug, HXR9, successfully halted tumor growth and induced apoptosis ... Read more

March 16, 2016March 16, 2016

U.S. Senate Designates Start of April 2016 to Be ‘National Asbestos Awareness Week’

News

The Asbestos Disease Awareness Organization (ADAO) has commended the U.S. Senate for unanimously passing a resolution to designate the first week of April 2016 to be National Asbestos Awareness Week, corresponding with the ADAO’s 12th annual conference. ADAO ... Read more

March 15, 2016March 15, 2016

Researchers Develop New Mouse Model of Malignant Mesothelioma to Study Interaction in Cancer Cells, Immune System

News

Researchers from San Raffaele Hospital in Milan, Italy, created and extensively characterized a new mouse model of malignant mesothelioma. The model allows the researchers to study the interactions between cancer cells and ... Read more

March 14, 2016March 14, 2016

Possible Malignant Mesothelioma Treatment Target Might Be HOX Genes

News

HOX is a family of genes well–known to be dysregulated in several forms of cancer. British researchers now reported that the expression of HOX genes is also disrupted in malignant mesothelioma, ... Read more

March 11, 2016March 11, 2016

Mesothelioma Study Sees Treatment Possibilities in Flaxseed-derived Compound That Prevented Cell Death

News

A study reported a potential new treatment for mesothelioma, lignan secoisolariciresinol diglucoside (LGM2605), which prevented cell death as a result of mouse macrophages brought into contact with asbestos and the subsequent formation of ... Read more

March 10, 2016March 10, 2016

Advanced Pleural Mesothelioma Patients Show Improved Survival with Higher Doses of Amatuximab

News

Researchers at the European Knowledge Centre (EKC) and the National Cancer Institute, working collaboratively, showed that a higher amatuximab dose in malignant pleural mesothelioma (MPM) patients was associated with longer overall survival. The ... Read more

March 9, 2016March 9, 2016

Pleural Mesothelioma Genomic Analysis Finds Some 2,700 Functional Mutation in Tumors

News

In a new comprehensive genomic study, researchers identified thousands of recurrent and protein-altering mutations in 216 malignant pleural mesothelioma (MPM) tumors. The analysis was performed using MedGenome’s OncoMD mutation database, ... Read more

March 8, 2016March 8, 2016

Pleural Mesothelioma Vaccine, WT1, Named ‘Orphan Drug’ by FDA to Advance Its Development

News

SELLAS Life Sciences Group recently announced that the U.S. Food and Drug Administration (FDA) has granted the company’s WT1 cancer vaccine Orphan Drug Designation as a potential treatment for patients with malignant pleural mesothelioma ... Read more

March 7, 2016March 7, 2016

Mesothelioma Lump-sum Payments Now Open All UK Veterans for Cancer Resulting from Service

News

As a result of a campaign led by The Royal British Legion, all military veterans in the United Kingdom with mesothelioma resulting from their service — regardless of when they were diagnosed ... Read more

March 4, 2016March 4, 2016

Idiopathic Pulmonary Fibrosis Deaths Seen to Be Linked to Asbestos Use in UK Study of 20th Century Data

News

British scientists have found a clear and lineal relationship between asbestos imported into the country and the number of annual deaths attributed to idiopathic pulmonary fibrosis (IPF). The more asbestos ... Read more